Yıl: 2021 Cilt: 28 Sayı: 1 Sayfa Aralığı: 106 - 112 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2020.09.907 İndeks Tarihi: 28-06-2021

Assessment of pulmonary functions with spirometry method in hepatic impairment patients

Öz:
Aim: In this study, it has been aimed to investigate whether there is a relationship between pulmonary functions measured by spirometry and hepatic impairment tables. This may contribute to a better understanding of the mechanisms of liver pathophysiology which hasn’t been fully understood.Materials and Methods: This study is a randomized controlled prospective trial. 39-63 years of age, 19 male and 9 female, a total of 28 patients diagnosed with liver failure, with 15 male and 17 female, a total of 32 healthy volunteers with similar social characteristics were studied. All of the participants’ pulmonary parameters (FEV1, FVC, FEV1/FVC, PEF, FEF25-75%, FEF25%, FEF50%, FEF75%, PIF, VC, MVV) were performed by pulmonary function tests (PFT). Groups’ data have been analyzed statistically. The significance levelwas considered as p<0.05.Results: In hepatic impairment patients, there was no significant difference in terms of the expected percentage values of PFT parameters that indicate obstruction. Weak restriction in 8 cases, moderate restriction in 9 cases and severe restriction in 4 cases were diagnosed. PFT parameters of patients with mid-level and refractory ascites were found to be significantly lower comparedwith those without ascites (FEV1: p=0.009; FVC: p=0.010; VC: p=0.008). There was no remarkable correlation between AST, ALT, ALP, GGT levels and PFT parameters of patients as with ascites status.Conclusion: Ascites that can frequently coexist with chronic liver disease cases, may cause restrictive type pulmonary dysfunctions in PFT by creating mechanical pressure. But also, there is no correlation between the ascites status or PFT diagnoses and liver function tests.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Manns MP, Burra P, Sargent J, et al. The Lancet-EASL Commission on liver diseases in Europe: Overcoming unmet needs, stigma, and inequities. Lancet 2018;392:621-2.
  • 2. Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity. Semin Liver Dis 2019;39:221-34.
  • 3. Lima LCD, Miranda AS, Ferreira RN, et al. Hepatic encephalopathy: Lessons from preclinical studies. World J Hepatol 2019;11:173-85.
  • 4. Chauhan A, Webb G, Ferguson J. Clinical presentations of Hepatitis E: A clinical review with representative case histories. Clin Res Hepatol Gastroenterol 2019;43:649-57.
  • 5. Artzner T, Michard B, Besch C, et al. Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals. World J Gastroenterol 2018;24:5203-14.
  • 6. Murphy N, Auzinger G, Bernel W, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004;39:464-70.
  • 7. Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology 2014;59:1627-37.
  • 8. Mızrak D, İdilman R. Karaciğer nakli: Hasta seçimi, gelişen endikasyonlar. Türkiye Klinikleri J Gen Surg 2009;2:10-3.
  • 9. Yalçın K. Karaciğer hastalıklarında semptomlar. In: Değertekin H, Yalçın K, eds. Karaciğer Hastalıklarına Klinik Yaklaşım. 1st edition. İstanbul: Pars Yayıncılık; 2009. p. 29-36.
  • 10. Krowka MJ, Cortese DA. Pulmonary aspects of chronic liver disease and liver transplantation. Mayo Clin Proc 1985;60:407-18.
  • 11. Çağlar T, Ilgaz A. Solunum Fonksiyon Testleri ve Klinik Kullanımı. 1st edition. Nobel Tıp Kitabevi, İstanbul, 2004; 1-102.
  • 12. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
  • 13. Rodriguez-Roisin R, Bartolome SD, Huchon G, et al. Inflammatory bowel diseases, chronic liver diseases and the lung. Eur Respir J 2016;47:638-50.
  • 14. Krovvka MJ, Cortese DA. Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation. Hepatology 1990;11:138-42.
  • 15. Krovvka MJ, Cortese DA. Hepatopulmonary syndrome: Current concept in diagnostic and therapeutic considerations. Chest 1994;105:1528-37.
  • 16. Rodriguez-Roisin R, Agusti AGN, Roca J. The hepatopulmonary syndrome: New name, old complexities. Thorax 1992;47:897-902.
  • 17. Kennedy TC, Knudson RL. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1977;72:305-9.
  • 18. Osni Leão Perin P, de Fátma Ferreira Santana Boin I, Oliveira da Silva AM, et al. Lung ultrasound and pulmonary function test in cirrhotic patients. Transplant Proc 2017;49:824-8.
  • 19. Yao EH, Kong B, Hsue G, et al. Pulmonary function changes in cirrhosis of the liver. Am J Gastroenterol 1987;82:352-4.
  • 20. Hourani JM, Bellamy PE, Tashkin DP, et al. Pulmonary dysfunction in advanced liver disease: Frequent occurence of an abnormal diffusing capacity. Am J Med 1991;90:693-700.
  • 21. Behara D, Singh M, Chawla Y, et al. Pulmonary function abnormality in patients with portal hypertension with or without chronic disease. Indean J Chest Dis Allied Sci 1998;40:33-9.
  • 22. Melot C, Naeije R, Dechamps P, et al. Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis. Am Rev Respir Dis 1989;139:632-40.
  • 23. Doğruer K, Ocak İ, Koçak B, et al. Karaciğer transplantasyonunda yoğun bakım yönetimi. Yoğun Bakım Dergisi 2007;7:417-25.
  • 24. Keshavan VH, Swamy CM. Pre-operative laboratory testing: A prospective study on comparison and cost analysis. Indian J Anaesth 2016;60:838-42.
  • 25. Karim HM, Yunus M, Bhattacharyya P. An observational cohort study on pre-operative investigations and referrals: How far are we following recommendations? Indian J Anaesth 2016;60:552-9.
  • 26. MacPherson RD, Reeve SA, Stewart TV, et al. Effective strategy to guide pathology test ordering in surgical patients. ANZ J Surg 2005;75:138-43.
  • 27. Bryson GL. Has preoperative testing become a habit? Can J Anaesth 2005;52:557-61.
  • 28. Kaplan EB, Sheiner LB, Boeckmann AJ, et al. The usefulness of preoperative laboratory screening. JAMA 1985;253:3576-81.
  • 29. Johnson RK, Mortimer AJ. Routine pre-operative blood testing: Is it necessary? Anaesthesia 2002;57:914-7.
  • 30. Benarroch-Gampel J, Sheffield KM, Duncan CB, et al. Preoperative laboratory testing in patients undergoing elective, low-risk ambulatory surgery. Ann Surg 2012;256:518-28.
  • 31. Guttikonda N, Nileshwar A, Rao M, et al. Preoperative laboratory testing - Comparison of National Institute of Clinical Excellence guidelines with current practice - An observational study. J Anaesthesiol Clin Pharmacol 2019;35:227-30.
APA DEMİREL S, COSKUN F, Nak S, OZYENER F (2021). Assessment of pulmonary functions with spirometry method in hepatic impairment patients. , 106 - 112. 10.5455/annalsmedres.2020.09.907
Chicago DEMİREL Sadettin,COSKUN FUNDA,Nak Selim Giray,OZYENER FADIL Assessment of pulmonary functions with spirometry method in hepatic impairment patients. (2021): 106 - 112. 10.5455/annalsmedres.2020.09.907
MLA DEMİREL Sadettin,COSKUN FUNDA,Nak Selim Giray,OZYENER FADIL Assessment of pulmonary functions with spirometry method in hepatic impairment patients. , 2021, ss.106 - 112. 10.5455/annalsmedres.2020.09.907
AMA DEMİREL S,COSKUN F,Nak S,OZYENER F Assessment of pulmonary functions with spirometry method in hepatic impairment patients. . 2021; 106 - 112. 10.5455/annalsmedres.2020.09.907
Vancouver DEMİREL S,COSKUN F,Nak S,OZYENER F Assessment of pulmonary functions with spirometry method in hepatic impairment patients. . 2021; 106 - 112. 10.5455/annalsmedres.2020.09.907
IEEE DEMİREL S,COSKUN F,Nak S,OZYENER F "Assessment of pulmonary functions with spirometry method in hepatic impairment patients." , ss.106 - 112, 2021. 10.5455/annalsmedres.2020.09.907
ISNAD DEMİREL, Sadettin vd. "Assessment of pulmonary functions with spirometry method in hepatic impairment patients". (2021), 106-112. https://doi.org/10.5455/annalsmedres.2020.09.907
APA DEMİREL S, COSKUN F, Nak S, OZYENER F (2021). Assessment of pulmonary functions with spirometry method in hepatic impairment patients. Annals of Medical Research, 28(1), 106 - 112. 10.5455/annalsmedres.2020.09.907
Chicago DEMİREL Sadettin,COSKUN FUNDA,Nak Selim Giray,OZYENER FADIL Assessment of pulmonary functions with spirometry method in hepatic impairment patients. Annals of Medical Research 28, no.1 (2021): 106 - 112. 10.5455/annalsmedres.2020.09.907
MLA DEMİREL Sadettin,COSKUN FUNDA,Nak Selim Giray,OZYENER FADIL Assessment of pulmonary functions with spirometry method in hepatic impairment patients. Annals of Medical Research, vol.28, no.1, 2021, ss.106 - 112. 10.5455/annalsmedres.2020.09.907
AMA DEMİREL S,COSKUN F,Nak S,OZYENER F Assessment of pulmonary functions with spirometry method in hepatic impairment patients. Annals of Medical Research. 2021; 28(1): 106 - 112. 10.5455/annalsmedres.2020.09.907
Vancouver DEMİREL S,COSKUN F,Nak S,OZYENER F Assessment of pulmonary functions with spirometry method in hepatic impairment patients. Annals of Medical Research. 2021; 28(1): 106 - 112. 10.5455/annalsmedres.2020.09.907
IEEE DEMİREL S,COSKUN F,Nak S,OZYENER F "Assessment of pulmonary functions with spirometry method in hepatic impairment patients." Annals of Medical Research, 28, ss.106 - 112, 2021. 10.5455/annalsmedres.2020.09.907
ISNAD DEMİREL, Sadettin vd. "Assessment of pulmonary functions with spirometry method in hepatic impairment patients". Annals of Medical Research 28/1 (2021), 106-112. https://doi.org/10.5455/annalsmedres.2020.09.907